SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001078782-19-000433
Filing Date
2019-05-14
Accepted
2019-05-14 16:08:03
Documents
33
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10Q QUARTERLY REPORT f10q033119_10q.htm 10-Q 174297
2 EXHIBIT 31.1 AND 31.2 SECTION 302 CERTIFICATIONS f10q033119_ex31z1.htm EX-31.1 7839
3 EXHIBIT 32.1 AND 32.2 SECTION 906 CERTIFICATIONS f10q033119_ex32z1.htm EX-32.1 3773
  Complete submission text file 0001078782-19-000433.txt   865673

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT marz-20190331_cal.xml EX-101.CAL 15727
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT marz-20190331_def.xml EX-101.DEF 26749
6 XBRL INSTANCE DOCUMENT marz-20190331.xml EX-101.INS 67103
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT marz-20190331_lab.xml EX-101.LAB 87283
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT marz-20190331_pre.xml EX-101.PRE 74302
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT marz-20190331.xsd EX-101.SCH 11649
Mailing Address 2295 TOWNE LAKE PKWY STE 116-290 WOODSTOCK GA 30189
Business Address 2295 TOWNE LAKE PKWY STE 116-290 WOODSTOCK GA 30189 925-400-3123
MARIZYME INC (Filer) CIK: 0001413754 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53223 | Film No.: 19822758
SIC: 2834 Pharmaceutical Preparations